News
Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.
Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.
Data suggest that the United States had the second highest number of mesothelioma cases and the second highest number of deaths from mesothelioma in 2021. These data were published in Lung Cancer. For ...
Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.
Study reveals Medicaid and private insurance copay rates are similar for adults 50 years and older using portal messaging.
Our real-world findings indicate that most patients undergoing multiple lines of therapy experience persistent treatment refractoriness and low response rates,” the researchers wrote.
Researchers studied trends in survival following FDA approval of immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma.
The rate of appropriate treatment suggestions was 86.6% for Claude3-Opus, 85.7% for GPT4-Turbo, and 75.0% for LLaMa3-70B. Artificial intelligence (AI) can accurately suggest appropriate adjuvant ...
Investigators conducted a systematic review and meta-analysis of more than 100 studies primarily from Asia, Europe, and the US to evaluate hepatocellular carcinoma outcomes on the basis of age.
An effort to reduce delays in treatment of head and neck cancer included integrating a school of dentistry with the surgical oncology clinic for timely oral assessment and care.
Ensuring timely completion of post-approval studies and enforcing appropriate regulatory actions based on negative trial results is necessary to minimize patient exposure to ineffective and ...
Strategies for helping the children of patients with cancer cope with their parent’s disease, treatment, and prognosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results